2Koyama T, Hirosawa S, Kawamata N, et al. All-trans Retinoic Acid Upregulates and Downregulates Tissue Factor Expression in APL:Distinct Expression of Thrombomodulin and Tissue Factor in Human Leukemic Cells. Blood, 1994,84(5):3001.
3Barbui T, Finazzi G, Falanga A. The Impact of ATRA on the Coagulopathy of Acute Promyelocytic Leukemia. Blood, 1998,91(9) :3093.
4GUO Weimin, WPAG Hongli, ZHAO Weili, et al. Effects of ATRA and As2O3 on TF Expression in APL Cells. Chinese Med J.2001, 114(1):30.
5Tallman M, Kwaan H. Reassesing the Hemostatic Disorder Associated with Acute Promyelocytic Leukemia. Blood, 1992,79(3) :543.
6Ferrara F, Palmieri S, Mele G. Prognostic factors and therapentic options for relapse or refractory acute myeloid leukemia. Haematologica, 2004, 89:998- 1008.
7Tallman M, Nabhan C. Managent of acute promyelocytic leukemia. Curr Oncol Rep, 2002, 4:381-389.
8Fenaux P, Chastang C, Chevret S, et al. A randomized comparise of all-trans retinoic acute promyelocytix leukemia. The Europea APL Group. Blood, 1999, 94:1192-1200.
9Fenaux P, Chevret S, Guerci A, et al. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. Leukemia, 2000, 14:1371-1377.
10Ohno R, Asou N, Ohnishi K, et al. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia, 2003, 17:1454-1463.
